Current Pharmaceutical Design
Bentham Science Publishers · United Arab Emirates · Est. 1840
✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journal’s page ↗The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.
Aims & Scope
Bentham aims to inform about the latest scientific developments in the area of illegal and prescription drugs and addiction. Topics covered include drug science, genetics, the latest academic research and information on addiction treatment. The mission is to educate the public and professionals about the science of drugs and drug addiction, including information regarding the causes of drug addiction and the associated consequences, as well as addiction treatment. They cover the latest scientific revelations regarding drugs and drug addiction by monitoring scientific journals dealing with this subject, aiming to educate the public using simple and easy to understand language.
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
Frequently asked questions about Current Pharmaceutical Design
Is Current Pharmaceutical Design a predatory journal?
PubScope has no integrity flags on record for Current Pharmaceutical Design: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Current Pharmaceutical Design?
Current Pharmaceutical Design is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.36.
Is Current Pharmaceutical Design indexed in Scopus and Web of Science?
Current Pharmaceutical Design is indexed in Web of Science, Scopus.
What is the aims and scope of Current Pharmaceutical Design?
Bentham aims to inform about the latest scientific developments in the area of illegal and prescription drugs and addiction. Topics covered include drug science, genetics, the latest academic research and information on addiction treatment. The mission is to educate the public and professionals about the science of drugs and drug addiction, including information regarding the causes of drug addiction and the associated consequences, as well as addiction treatment. They cover the latest scientific revelations regarding drugs and drug addiction by monitoring scientific journals dealing with this
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref